News & Updates

For adults undergoing surgery, melatonin appears to help reduce the likelihood of postoperative delirium, according to the results of a meta-analysis.

Growth hormone (GH), compared with catecholamines, appears to be a better facilitator for the change from glucose to fatty acid metabolism following SGLT2 inhibitor use during exercise, reveals a study.

A phase II nonrandomized trial of trabectedin in combination with radiotherapy for the treatment of myxoid liposarcoma has failed to meet its endpoint, although this treatment combination appears to be well tolerated in patients.

Sarecycline demonstrated efficacy for the treatment of moderate-to-severe facial acne vulgaris in patients with skin of colour, according to a post hoc analysis of two phase III trials presented at AAD 2023.

When added to chemotherapy, disulfiram and copper do not appear to yield survival benefits in patients with recurrent glioblastoma, even leading to an increased frequency of adverse events, as shown in the results of an open-label, randomized phase II/III study.

Eribulin and trabectedin show significant antitumour activity in advanced pleomorphic liposarcoma as compared with conventional chemotherapy, according to retrospective data from the Gustave Roussy cancer centre presented at ESMO SARCOMA 2023.